American Tegumentary leishmaniasis (ATL) is an infectious disease caused by
several species of
Leishmania
. Even though the direct
detection of parasites has low sensitivity, it is still the gold standard for
the laboratory diagnosis of ATL. Recent studies have shown promising results of
Enzyme-Linked Immunosorbent Assays
(
ELISAs) using recombinant
antigens. The aim of this study is to compare the accuracy of ELISAs using novel
antigens with the standard ELISA based on soluble antigens of
Leishmania
(SLA) to diagnose ATL. Studies that analyzed
patients with ATL and studies that evaluated the diagnostic accuracy of ELISAs
using novel antigens and SLA were included. The Fourteen studies from PubMed,
Regional Portal of the Virtual Health Library (BVS), Brazilian Society of
Dermatology, Virtual Health Library (IBECS), Literature in the Health Sciences
in Latin America and the Caribbean (LILACS), Medical Literature Analysis and
Retrieval System Online (Medline), Elsevier Embase, Cochrane Library, The
National Institute for Health and Care Excellence (NICE), and Cumulative Index
to Nursing and Allied Health Literature (CINAHL) were included. The novel ELISA
antigens showed a high sensitivity (93.8%-100%) and specificity (82.5-100%), a
better diagnostic performance than SLA-based ELISAs (1-97.4% and 57.5-100%,
respectively). Only 10 studies analyzed cross-reactions in serum samples from
patients with Chagas disease, and only two studies reported a percentage of
cross-reactivity. In this systematic review, the novel ELISA antigens showed
better sensitivity and specificity with respect to SLA-based ELISAs. However, a
meta-analysis should be performed to confirm this finding.